Nurix Therapeutics, Inc. (NASDAQ: NRIX) reported Q1 EPS of ($0.76), $0.02 better than the analyst estimate of ($0.78). Revenue for the quarter came in at $16.58 million versus the consensus estimate of $17.08 million.

For earnings history and earnings-related data on Nurix Therapeutics, Inc. (NRIX) click here.